pancreatic cancer Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers Immunovia said that it has secured intellectual property rights to the biomarkers, which are part of the diagnostic signature for its Immray PanCan-d blood test. Konica Minolta Joins Precede Consortium to Improve Diagnosis and Treatment of Pancreatic Cancer The company will employ its Lattice platform to shepherd and translate genomic and other data toward the development of new early diagnostics and interventions. Bluestar Genomics Raises $70M in Series C Funding Round The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board. BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research The partners will look for patterns in patients' exome sequencing and transcriptomics data to try to predict treatment response. Immunovia Preparing to Launch Laboratory-Developed Test for Pancreatic Cancer Premium The firm said that recent validation studies have shown that a positive result with its PanCan-d microarray test could accelerate diagnosis for high-risk individuals. Apr 14, 2021 Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Mar 1, 2021 TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine Premium Feb 1, 2021 Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker Dec 17, 2020 Merus, Sema4 Partner to Accelerate Enrollment in Zenocutuzumab Trial Nov 2, 2020 Bluestar Genomics Eyes Pan-Cancer Early Detection With Epigenetic Assay Technology Premium Oct 16, 2020 Pancreatic Cancer Subtype With Poor Outcomes Shows Low Methylation, High Interferon Signature Oct 13, 2020 Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform Oct 12, 2020 Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 16, 2020 Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable Premium Sep 15, 2020 Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles Sep 9, 2020 NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities Jul 31, 2020 Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues Premium Jul 29, 2020 Pancreatic Cancer Action Network, GeneCentric Therapeutics Launch Research Partnership Jun 11, 2020 Seven Bridges Building Research Platform for PanCAN May 29, 2020 Tumor Microbiome Appears to Vary With Cancer Type Apr 22, 2020 Pancreatic Cancer Clinical Risk Prediction Appears to Improve With Genetic, Biomarker Data Apr 16, 2020 Multi-Analyte Liquid Biopsy Panel May Aid in Pancreatic Cancer Detection, Staging Premium Apr 16, 2020 Human Tumor Atlas Network Team Shares Strategy for Tracking Tumor Transitions Mar 30, 2020 Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.